Skip to Main Content

Advertisement

Skip Nav Destination

Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity

Mol Cancer Ther (2022) 21 (2): 382–394.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Lindsay A. Bischoff
  • Ian Ganly
  • Laura Fugazzola
  • Erin Buczek
  • William C. Faquin
  • Bryan R. Haugen
  • Bryan McIver
  • Caitlin P. McMullen
  • Kate Newbold
  • Daniel J. Rocke
  • Marika D. Russell
  • Mabel Ryder
  • Peter M. Sadow
  • Eric Sherman
  • Maisie Shindo
  • David C. Shonka
  • Michael C. Singer
  • Brendan C. Stack
  • Lori J. Wirth
  • Richard J. Wong
  • Gregory W. Randolph
JAMA Otolaryngology–Head & Neck Surgery (2024) 150 (3): 265.
  • Bin Xu
  • Daniel J. Lubin
  • Snjezana Dogan
  • Ronald A. Ghossein
  • Kartik Viswanathan
Virchows Archiv (2023) 482 (3): 479.
  • Raj K. Gopal
  • Venkata R. Vantaku
  • Apekshya Panda
  • Bryn Reimer
  • Sneha Rath
  • Tsz-Leung To
  • Adam S. Fisch
  • Murat Cetinbas
  • Maia Livneh
  • Michael J. Calcaterra
  • Benjamin J. Gigliotti
  • Kerry A. Pierce
  • Clary B. Clish
  • Dora Dias-Santagata
  • Peter M. Sadow
  • Lori J. Wirth
  • Gilbert H. Daniels
  • Ruslan I. Sadreyev
  • Sarah E. Calvo
  • Sareh Parangi
  • Vamsi K. Mootha
Cancer Discovery (2023) 13 (8): 1904.
  • Costanza Chiapponi
  • Milan J.M. Hartmann
  • Matthias Schmidt
  • Michael Faust
  • Christiane J. Bruns
  • Anne M. Schultheis
  • Hakan Alakus
Frontiers in Endocrinology (2022) 13
Close Modal

or Create an Account

Close Modal
Close Modal